medigraphic.com
ISSN 2007-8560 (Print)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2013, Number 2

<< Back Next >>

Ortho-tips 2013; 9 (2)

Thromboembolism and fractures

González RJL

Language: Spanish
References: 25
Page: 118-128
PDF size: 156.46 Kb.


ABSTRACT

Venous thromboembolism has been identified as the leading cause of preventable death in hospitalized patients. The pulmonary embolism is considered the 3rd leading cause of death after trauma in patients who survive more than 24 hours and the sequels of those who stayed hospitalized are pulmonary hypertension, chronic venous insufficiency and post-thrombotic syndrome represents a higher cost. Unlike the incidence of events that happen in major orthopedic surgery (total or partial prosthetic hip and knee) difficult start prophylaxis, occurs in patients with a fracture or multiple injuries, hence to know the exact time of onset and duration of drug therapy alone or combinated with mechanical methods. It is necessary to make a scale of risk factors ​​based on the diversity of events experienced by the patient. Therefore, we must make three successful strategies to minimize or avoid the risk of thromboembolism in patients with fracture(s); first, knowledge of the disease and its causes both acquired as hereditary, anticoagulants and their effective application and safety, and use diagnostic aids resources to avoid complications. The orthopedic surgeon requires complete knowledge and experience in treatment, knowing the Clinical Practice Guide for Venous Thrombosis, and know at what point have the support of several specia­lists in benefit of the patient.


REFERENCES

  1. Kahn SR, Ginsberg JS. Post thrombotic syndrome. Arch In Med. 2004; 16417-16426.

  2. Kahn SR, Ginsberg JS. Post thrombotic syndrome. J Thromb Thrombolysis. 2006; 21: 41-48.

  3. Siglier ML, Castañeda GR, Athié RJ. Trombosis venosa profunda y emboliapulmonar. México: McGraw-Hill Interamericana; 2002.

  4. Siglier L, Romero T, Meillón LA, Gutiérrez L, Aguirre GJ, Esparza C. Tromboembolia pulmonar en un periodo de 10 años. Rev Med IMSS. 1996; 34: 7-11.

  5. Cabrera-Rayo A, Nellen-Hummel H. Epidemiología de la enfermedad tromboembólica venosa. Gac Med Mex. 2007; 143 (Supl 1): 3-5.

  6. Margaret KM, Ikossi GD. Venous thromboembolism after trauma. Current Opinion in Critical Care. 2004; 10: 539-548.

  7. Virchow RC. Die cellularpathologie in ihrer Begründung auf physiologische. 1858; 1858.

  8. Wells PS, Ginsberg JS, Anderson DR, et al. Value of assessment of pretest probality of depp-vein thrombosis in clinical management. Lancet. 1997; 350: 1795-1798.

  9. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005; 51: 70-78.

  10. Geerts WH, BergqvistD, Pineo GF, Lassen MR, et al. Prevention of venous thromboembolism-American Colle of chest physicians evidence-based clinical practice guidelines (8th Ed). Chest. 2008; 133: 381S-453S.

  11. Helfey FG Jr, Nelson CL, Puskarich-May CL. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein-thrombosis associated with fractures about the hip. J Bone Joint Surg Am. 1996; 78: 581-583.

  12. Geerts WH, Code Kl, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994; 331: 1601-1606.

  13. Pitto RP, Hamer H, Heiss-Dunlop. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomized clinical trial. JBJS Br. 2004; 86 (5): 639-642.

  14. Warwick D, Harrison J, Glew D, Michelmore A. Peters. Comparison of the use of foot pump with the use of low-molecular-weigth heparin for the prevention of deep-vein trombosis after total hip replacement a prospective, randomized trial. J Bone Joint Surg Am. 1998; 80 (8): 1158-1166.

  15. Schulman S, Beyth RJ, Kearson C, Levine MN. Hemorragic complications of anticoagulant and thrombolytic treatment. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Ed). Chest. 2008; 133: 257S-298S.

  16. Becker CR. Aspirin and the prevention of venous thromboembolism. Editorial N Engl J Med. 2012; 366; 2028-2030.

  17. Hirsch J, Gordon G, Albers WG. Executive summary. American College of Chest Physicians (8th Ed) 133: 71S-105S.

  18. The East Practice Management Guidelines Work Group. Practice management guidelines for the preventions of venous thromboembolism in trauma patients. J Trauma. 2002; 53: 142-164.

  19. Navarro-Quilis A, Castellet E, Rocha E, Planès A; Bemiparin study group in knee arthroplasty. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double blind clinical trial. Journal of Thromb Haemost. 2003; 1: 425-432.

  20. Ericsson B, et al. Record 2 study comparative enoxaparin rivaroxaban. N Engl J Med. 2008; 358: 2765-2775.

  21. Strebel N, Prins M, Agnelli G. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low molecular-weigth heparin in elective hip surgery. Arch Intern Med. 2002; 162 (13): 1451-1456.

  22. Alcantar LE, Carrillo-Esper R, Herrera-Cornejo MA, Jaimovich D y cols. Guía de práctica clínica de profilaxis y manejo de la enfermedad tromboembólica en pacientes hospitalizados, basada en indicadores medibles de calidad hospitalaria. Med Int Mex. 2011; 27 (4): 356-369.

  23. Harvin JA, Harvin WH, Camp E. Early femur fracture fixation is associated with a reduction in pulmonary complications and hospital charges: a decade of experience with 1,376 diaphyseal femur fractures. J Trauma Acute Care Surg. 2012; 73 (6): 1442-1449.

  24. Kim DY, Kovayashi L, et al. Venous thromboembolism in the elderly: the result of comorbid conditions or a consequence of injury? J Trauma Acute Care Surg. 2012; 72 (5): 1286-1291.

  25. Slobogean PG, Lefaivre AK, et al. A systematic review of thromboprophylaxis for pelvic and acetabular fractures. J Orthop Trauma. 2009; 23 (5): 379-384.




2020     |     www.medigraphic.com